90%Confidence
0Views
FDASource
2026-04-16Date
Summary
Dry eye relief products from K.C. Pharmaceuticals now included in sterility failures, affecting Gericare, TopCare, and Rite Aid brands. The pattern suggests fundamental contamination issues across their entire eye care manufacturing operations.
Actionable: Assess market share shifts in OTC eye care products as consumers seek alternatives to affected brands.
AI Confidence: 90%
Data Points
firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productDry Eye Relief Eye Drops, (glycerin 0.2%, hypromellose 0.2% and polyethylene glycol 400 1%) 0.5 FL OZ (15 mL) bottles; a) GERI CARE, Distributed by:
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now